Literature DB >> 31205070

Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections.

Angela R Omilian1,2, Gary R Zirpoli3, Ting-Yuan David Cheng1,4, Song Yao1, Leighton Stein2, Warren Davis1, Karen L Head2, Priya Nair1, Thaer Khoury2, Christine B Ambrosone1, Wiam Bshara2.   

Abstract

Loss of immunoreactivity in tissue sections has been shown to occur when slide sections are stored at room temperature for prolonged periods of time. We conducted a systematic investigation to determine the extent of staining loss in various storage conditions to determine an optimal storage method. We investigated 6 antibodies that are commonly used for breast cancer subtyping in research studies with immunohistochemistry (ER, PR, HER2, CK5/6, EGFR, and Ki67) in formalin-fixed paraffin-embedded breast tissue microarrays consisting of 148 patients. Tissue microarrays were sectioned at various time points: fresh, 1 week, 1 month, 6 months, and 12 months before staining. Slides sectioned at each time point were stored in 5 storage conditions: desiccator, paraffin dipped, 4°C, -20°C, and -80°C. Immunohistochemistry scores were assessed over time with McNemar Test and Bowker Test of Symmetry. Desiccator storage was the only storage condition that did not show any loss in immunoreactivity for any antibody or time point in our study. Paraffin coated slides were the most difficult storage method operationally and also showed the most loss in immunoreactivity. Storing sections in a desiccator was the most effective method for minimizing immunoreactivity loss. Cold storage at 4°C is an intermediate option that is not as protective as a desiccator, but offers the advantage of being accessible to virtually all research labs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31205070      PMCID: PMC6906262          DOI: 10.1097/PAI.0000000000000756

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  32 in total

1.  Assessment of problems in diagnostic and research immunohistochemistry associated with epitope instability in stored paraffin sections.

Authors:  L J van den Broek; M J van de Vijver
Journal:  Appl Immunohistochem Mol Morphol       Date:  2000-12

2.  Long-term preservation of antigenicity on tissue microarrays.

Authors:  Kyle A DiVito; Lori A Charette; David L Rimm; Robert L Camp
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

3.  Detectability of retinoblastoma (Rb) gene product and p53 antigen expression decreases in stored paraffin sections.

Authors:  I Songun; C J van der Velde; G Gramer-Knijnenburg; J H van Krieken
Journal:  Histopathology       Date:  1997-06       Impact factor: 5.087

4.  Digital image analysis outperforms manual biomarker assessment in breast cancer.

Authors:  Gustav Stålhammar; Nelson Fuentes Martinez; Michael Lippert; Nicholas P Tobin; Ida Mølholm; Lorand Kis; Gustaf Rosin; Mattias Rantalainen; Lars Pedersen; Jonas Bergh; Michael Grunkin; Johan Hartman
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

5.  Evaluation of methods for preserving PTEN antigenicity in stored paraffin sections.

Authors:  Arnold B Gelb; Vicki A Freeman; Stephanie H Astrow
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-12

6.  Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections.

Authors:  Ran Xie; Joon-Yong Chung; Kris Ylaya; Reginald L Williams; Natalie Guerrero; Nathan Nakatsuka; Cortessia Badie; Stephen M Hewitt
Journal:  J Histochem Cytochem       Date:  2011-02-10       Impact factor: 2.479

7.  A Call to Standardize Preanalytic Data Elements for Biospecimens, Part II.

Authors:  James A Robb; Lynn Bry; Patrick M Sluss; Elizabeth A Wagar; Mary F Kennedy
Journal:  Arch Pathol Lab Med       Date:  2015-01-16       Impact factor: 5.534

8.  Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.

Authors:  Julie R Palmer; Emma Viscidi; Melissa A Troester; Chi-Chen Hong; Pepper Schedin; Traci N Bethea; Elisa V Bandera; Virginia Borges; Craig McKinnon; Christopher A Haiman; Kathryn Lunetta; Laurence N Kolonel; Lynn Rosenberg; Andrew F Olshan; Christine B Ambrosone
Journal:  J Natl Cancer Inst       Date:  2014-09-15       Impact factor: 13.506

9.  Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains.

Authors:  Mary Economou; Liliane Schöni; Caroline Hammer; José A Galván; Dominique-Elisabeth Mueller; Inti Zlobec
Journal:  Clin Transl Med       Date:  2014-03-17

10.  Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.

Authors:  Emma H Allott; Joseph Geradts; Xuezheng Sun; Stephanie M Cohen; Gary R Zirpoli; Thaer Khoury; Wiam Bshara; Mengjie Chen; Mark E Sherman; Julie R Palmer; Christine B Ambrosone; Andrew F Olshan; Melissa A Troester
Journal:  Breast Cancer Res       Date:  2016-06-28       Impact factor: 6.466

View more
  2 in total

1.  Low TINAGL1 expression is a marker for poor prognosis in breast cancer.

Authors:  Akiko Kato; Naoto Kondo; Yumi Wanifuchi-Endo; Takashi Fujita; Tomoko Asano; Tomoka Hisada; Yasuaki Uemoto; Mitsuo Terada; Hiroyuki Kato; Masayuki Komura; Katsuhiro Okuda; Satoru Takahashi; Tatsuya Toyama
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-14       Impact factor: 4.322

2.  Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker.

Authors:  Rogério Agenor de Araújo; Felipe Andrés Cordero da Luz; Eduarda da Costa Marinho; Camila Piqui Nascimento; Lara de Andrade Marques; Patrícia Ferreira Ribeiro Delfino; Rafael Mathias Antonioli; Breno Jeha Araújo; Ana Cristina Araújo Lemos da Silva; Maria Luiza Gonçalves Dos Reis Monteiro; Morun Bernardino Neto; Marcelo José Barbosa Silva
Journal:  Ecancermedicalscience       Date:  2022-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.